Inventor · disambiguated record
Kenneth Wilson
Also filed as: WILSON KENNETH · WILSON KENNETH J · WILSON KENNETH JEROME
35 granted patents·4 pending applications·474 citations·filing 1984–2023
97Inventor score
Files withJANSSEN PHARMACEUTICA NV21ILLIG CARL R6DIMENSIONAL PHARM INC5CHIRON CORP2BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
39 records- 0197US7645755B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jan 12, 2010·45 cites·7 claims
- 0295US7973035B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jul 5, 2011·24 cites·12 claims
- 0395US7414050B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 19, 2008·36 cites·16 claims
- 0495US4569790AProcess for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositionsCETUS CORP·Filed 1984·Granted Feb 11, 1986·81 cites·21 claims
- 0593US7795279B2Method of inhibiting FLT3 kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 14, 2010·30 cites·2 claims
- 0692US7662837B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 16, 2010·26 cites·22 claims
- 0790US6403633B2Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Jun 11, 2002·21 cites·108 claims
- 0887US6562840B1Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2002·Granted May 13, 2003·16 cites·36 claims
- 0986US6515002B2Compounds and compositions for treating C1s-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 4, 2003·26 cites·13 claims
- 1084US9266866B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 23, 2016·4 cites·9 claims
- 1184US8895584B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 25, 2014·4 cites·16 claims
- 1284US8859602B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2007·Granted Oct 14, 2014·4 cites·11 claims
- 1384US8815867B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2007·Granted Aug 26, 2014·4 cites·9 claims
- 1483US7030112B2Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disordersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 18, 2006·21 cites·2 claims
- 1583US6492403B1Methods of treating C1s-mediated diseases and conditions and compositions thereofDIMENSIONAL PHARM INC·Filed 2000·Granted Dec 10, 2002·22 cites·27 claims
- 1682US9193736B2PDE 10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 24, 2015·7 cites·14 claims
- 1780US8759347B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·3 cites·18 claims
- 1879US9296726B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Mar 29, 2016·2 cites·7 claims
- 1979US8722718B2Inhibitors of C-FMS kinaseILLIG CARL R·Filed 2007·Granted May 13, 2014·2 cites·10 claims
- 2077US8481564B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2011·Granted Jul 9, 2013·2 cites·19 claims
- 2176US9221797B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 29, 2015·2 cites·18 claims
- 2276US7705042B2Class of arylamide compounds useful as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 27, 2010·3 cites·11 claims
- 2375US6291514B1Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1999·Granted Sep 18, 2001·15 cites·60 claims
- 2474US5792450APurified human CSF-1CHIRON CORP·Filed 1995·Granted Aug 11, 1998·36 cites·3 claims
- 2572US9303046B2Process for the preparation of heterocyclic ester derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·1 cites·6 claims
- 2670US5614185ACompositions containing reduced, microbially produced interleukin-2 (IL-2)CHIRON CORP·Filed 1995·Granted Mar 25, 1997·24 cites·10 claims
- 2768US9526731B2Method of inhibiting C-KIT kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 27, 2016·0 cites·1 claims
- 2868US8697716B2Method of inhibiting C-KIT kinaseILLIG CARL R·Filed 2007·Granted Apr 15, 2014·0 cites·2 claims
- 2967US9403804B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 2, 2016·0 cites·11 claims
- 3067US9394289B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 19, 2016·0 cites·9 claims
- 3164US8933091B2Method of inhibiting C-KIT kinaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 13, 2015·0 cites·1 claims
- 3262US5419899APurified, reduced recombinant interleukin-2 compositionsFiled 1992·Granted May 30, 1995·13 cites·24 claims
- 3359US2016122334A1Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3459US2025134907A1Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereofUS HEALTH·Filed 2023·Application pending·0 cites
- 3556US8674100B2Inhibitors of C-FMS kinaseILLIG CARL R·Filed 2007·Granted Mar 18, 2014·0 cites·24 claims
- 3651US9452996B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 27, 2016·0 cites·16 claims
- 3751US2016168170A1Process for the preparation of heterocyclic ester derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3848US9249163B2PDE10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 2, 2016·0 cites·19 claims
- 3942US2013244929A1Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterialsGALLANT MICHEL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →